Transnational Cannabis Ltd
OTC:TRCNF
Transnational Cannabis Ltd
Research & Development
Transnational Cannabis Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Transnational Cannabis Ltd
OTC:TRCNF
|
Research & Development
-CA$5m
|
CAGR 3-Years
-316%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Research & Development
-$629m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Research & Development
-$4.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Research & Development
-$105.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-152%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Research & Development
-CA$27.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-26%
|
|
Transnational Cannabis Ltd
Glance View
Transnational Cannabis Ltd. is a biotechnology company that engages in the development and production of medical marijuana. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-08. The firm is engaged in the cultivation, extraction, formulation and distribution of cannabis internationally.
See Also
What is Transnational Cannabis Ltd's Research & Development?
Research & Development
-5m
CAD
Based on the financial report for Feb 28, 2019, Transnational Cannabis Ltd's Research & Development amounts to -5m CAD.
What is Transnational Cannabis Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-316%
The average annual Research & Development growth rates for Transnational Cannabis Ltd have been -316% over the past three years .